Latest Articles

  • Impact of Combination Medical Therapy on Mortality in Vascular Surgery Patients
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Thomas Barrett, Motomi Mori and Caroline Koudelka
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S24;
  • Perioperative Cardiac Arrest in a Patient with Aortic Stenosis: Is It Preventable?
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Zdravka Zafirova and Bobbie Sweitzer
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S34;
  • Electroconvulsive therapy: What the internist needs to know
    Mayur Pandya, DO, Leopoldo Pozuelo, MD and Donald Malone, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 679-685;

    Despite its bad reputation, electroconvulsive therapy is safe and effective for treating a number of psychiatric disorders. For some patients, it is the only therapy that works.

  • PONV: ‘An Ounce of Prevention is Worth a Pound of Cure’
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Catherine Capitula and Shari Duguay
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S26;
  • Does unrecognized diabetes in the preoperative period worsen postoperative outcomes?
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Krista Andersen-Harris, DO and Christopher Whinney, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S15-S16;
  • Ulcerative colitis: Responding to the challenges
    Jean-Paul Achkar, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 657-660;

    Aminosalicylates are the first-line therapy for patients with mild to moderate active ulcerative colitis. Infliximab is now approved for moderately to severely active ulcerative colitis in patients who have had an inadequate response to conventional therapy.

  • When Is a Stress Test Indicated in Patients with Chronic Kidney Disease Evaluated for Noncardiac Surgery?
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Vesselin Dimov, Kalina Uzunova-Dimova, Mitko Badov and Saira Noor
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S31;
  • Chronic Renal Insufficiency: An Oft-Forgotten Component of the Revised Cardiac Risk Index
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, Vesselin Dimov, Ashish Aneja and Kalina Uzunova-Dimova
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S31;
  • Interpreting the Courage Trial
    William E. Boden, MD
    Cleveland Clinic Journal of Medicine September 2007, 74 (9) 623-633;

    We found that as an initial management strategy in patients with stable coronary artery disease, percutaneous coronary intervention did not reduce the incidence of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.

  • Optimization of Perioperative Processes Through Innovation and Technology for the Orthopaedic Operating Room of the Future
    Amir K. Jaffer, MD, Franklin A. Michota, MD, Angela M. Bader, MD, MHP, Raymond Borkowski, MD, Collin Kroen, MD, Brian Harte, MD, David Gugliotti, MD, J.H. James Choi, Jennifer Blueter, Barbara Fahey, James Leonard, Ted Omilanowski, Vincent Riley, Mark Schauer, Timothy Sullivan, Viktor Krebs and Jonathan Schaffer
    Cleveland Clinic Journal of Medicine September 2007, 74 (9 esuppl 1) S26;

Pages